Xu, Q.; Huang, X.; Meng, Z.; Li, Y.; Zhong, R.; Li, X.; Cyganek, L.; El-Battrawy, I.; Akin, I.; Zhou, X.;
et al. Antiarrhythmic Effects of Vernakalant in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes from a Patient with Short QT Syndrome Type 1. J. Cardiovasc. Dev. Dis. 2022, 9, 112.
https://doi.org/10.3390/jcdd9040112
AMA Style
Xu Q, Huang X, Meng Z, Li Y, Zhong R, Li X, Cyganek L, El-Battrawy I, Akin I, Zhou X,
et al. Antiarrhythmic Effects of Vernakalant in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes from a Patient with Short QT Syndrome Type 1. Journal of Cardiovascular Development and Disease. 2022; 9(4):112.
https://doi.org/10.3390/jcdd9040112
Chicago/Turabian Style
Xu, Qiang, Xuemei Huang, Zenghui Meng, Yingrui Li, Rujia Zhong, Xin Li, Lukas Cyganek, Ibrahim El-Battrawy, Ibrahim Akin, Xiaobo Zhou,
and et al. 2022. "Antiarrhythmic Effects of Vernakalant in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes from a Patient with Short QT Syndrome Type 1" Journal of Cardiovascular Development and Disease 9, no. 4: 112.
https://doi.org/10.3390/jcdd9040112
APA Style
Xu, Q., Huang, X., Meng, Z., Li, Y., Zhong, R., Li, X., Cyganek, L., El-Battrawy, I., Akin, I., Zhou, X., & Lan, H.
(2022). Antiarrhythmic Effects of Vernakalant in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes from a Patient with Short QT Syndrome Type 1. Journal of Cardiovascular Development and Disease, 9(4), 112.
https://doi.org/10.3390/jcdd9040112
